Recently, China Classification Society Quality Certification Co., Ltd. (CCSC) completed the evaluation of the carbon footprint of Jiangzhong Pharmaceutical Co., Ltd.s Jianwei Xiaoshibei tablets and grass coral buccal tablets and issued a carbon footprint evaluation certificate.
The carbon footprint evaluation work carried out by CCSC in the pharmaceutical industry not only helps pharmaceutical enterprises to achieve remarkable results in ecological environment protection and green and low-carbon development, but also provides excellent reference cases for other enterprises in the pharmaceutical industry. Jiangzhong Pharmaceuticals two products, Jianwei Xiaohu Tablets and Compound Caoshanhu buccal tablets, have successfully obtained the carbon footprint evaluation certificate, which will help Jiangzhong Pharmaceutical to show stronger competitiveness in the future market.Carbon footprint assessment is based on the life cycle of a product or service, calculating the total amount of carbon dioxide and other greenhouse gas emissions. Through carbon footprint evaluation, we can clearly understand the source and total amount of carbon emissions of each process and process, help enterprises to tap the potential of reducing carbon emissions in the stages of product design, production and supply, and guide enterprises to carry out low-carbon production technology research and development and innovation.China Classification Society Quality Certification Co., Ltd. is one of the first third-party organizations in my country to set foot in the field of green and low-carbon. It takes independence, fairness, and integrity as its working criteria, and serves the countrys "dual carbon" from multiple perspectives such as scientific research, review, evaluation, and technical support. "Strategy, to make its own contribution to my countrys early realization of the" dual carbon "strategic goal and the longer-term green and low-carbon development in the future.
